Review
Copyright ©The Author(s) 2021.
World J Gastroenterol. Nov 21, 2021; 27(43): 7446-7461
Published online Nov 21, 2021. doi: 10.3748/wjg.v27.i43.7446
Table 2 Microbial changes as a result of several treatments in viral B and C hepatitis
Drug
Type of study
Changes in gut microbiota
Ref.
EntecavirExperimental (mice)Lachnospiraceae, Akkermansia, Alistipes, Escherichia, Shigella, Oscillibacter, BilophilaLi et al[127]
ClinicalClostridium sensu stricto 1, Erysipelotrichaceae UCG-007, Intestinibacter; ↓ Streptococcus, Atopobium, and MurdochiellaLu et al[128]
Direct antiviral agents in patients with HCV infectionClinicalPhylum Firmicutes, genera LachnospiraPérez-Matute et al[129]
Direct antiviral agents in patients with HCV-related liver cirrhosisClinicalEnterobacteriaceae, Staphylococcus and VeillonellaceaePonziani et al[130]